2025-07-16 - Analysis Report
Okay, here's an analysis of Transmedics Group Inc (TMDX) based on the data you provided. The report is in English with key figures highlighted and followed by a concise analysis.

## TMDX (Transmedics Group Inc) Stock Analysis

**Company Overview:** Transmedics Group Inc is a medical technology company focused on developing and delivering innovative organ preservation systems for transplantation.

### 1. Performance vs. S&P 500 (VOO)

*   **TMDX Cumulative Return:** 232.29%
*   **VOO Cumulative Return:** 66.56%
*   **Absolute Divergence (Current):** 162.8%
*   **Relative Divergence:** 63.0%

**Analysis:** TMDX has significantly outperformed the S&P 500.  The current divergence of 162.8% indicates substantial outperformance. The Relative Divergence of 63.0 suggests that TMDX's current outperformance is in the upper-middle range of its historical divergence from the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2019-2021  | -4.0%  | 63.4%  | -52.0% | 0.0   | 0.7    |
| 2020-2022  | 140.0% | 68.3%  | 138.0% | 0.1   | 2.1    |
| 2021-2023  | 95.0%  | 69.4%  | 77.0%  | 0.2   | 2.7    |
| 2022-2024  | 147.0% | 82.8%  | 121.0% | 0.2   | 2.1    |
| 2023-2025  | 113.0% | 82.8%  | 67.0%  | 0.5   | 3.9    |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  TMDX has experienced very high growth rates in recent years, with the exception of the 2019-2021 period.
*   **MDD (Maximum Drawdown):** The high MDD values indicate significant volatility and risk associated with the stock.
*   **Alpha:**  Strong positive Alpha values suggest that TMDX's returns are largely independent of the market.
*   **Beta:** Beta values have increased in the recent year, suggesting that TMDX's returns are becoming more sensitive to changes in the market.

### 2. Recent Price Action

*   **Current Price:** $115.68
*   **Previous Close:** $116.88
*   **Change:** -1.03%
*   **5-day Moving Average:** 119.24
*   **20-day Moving Average:** 127.08
*   **60-day Moving Average:** 118.84

**Analysis:**  The price is currently below all three moving averages, indicating a short-term downward trend. The recent -1.03% change suggests a small pullback. The price being below the 5-day and 20-day moving averages points to a potential continuation of the downtrend in the short term.

### 3. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.341 (Low Risk)
*   **RSI:** 31.52 (approaching oversold territory)
*   **PPO:** -1.85 (Negative, indicating a downward trend)
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (4 shares - Caution - MRI:0.35)
*   **20-day Relative Divergence Change:** -3.3 (decreasing outperformance)
*   **Expected Return:** 57.3% (over S&P 500 in the long term)

**Analysis:** The MRI suggests low market risk. The RSI is approaching oversold territory, which *could* signal a potential rebound. However, the negative PPO confirms the current downward trend. The Hybrid Signal suggests a cautious approach, recommending a slight reduction in holdings. The negative change in relative divergence reinforces the short-term underperformance relative to the S&P 500.  The high expected return suggests a positive long-term outlook. The recent negative change in price amplifies the recent downward trend issue.

### 4. Recent News & Events

*   **[2025-07-13]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-16]:** Analyst discussions on recent performance and industry trends.
*   **[2025-07-12]:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **[2025-07-15]:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news suggests increased volatility and scrutiny surrounding TMDX.  Investors should closely monitor company announcements, news, and analyst reports to understand the driving forces behind these events.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 예상 EPS |
|------------|------|----------|
| 2025-05-08 | 0.7  | 0.29     |
| 2025-02-27 | 0.19 | 0.22     |
| 2024-10-28 | 0.12 | 0.29     |
| 2024-07-31 | 0.35 | 0.21     |
| 2024-04-30 | 0.35 | 0.03256  |

**Analysis:** TMDX has generally exceeded EPS expectations in recent quarters, significantly surpassing them in the most recent quarter (2025-05-08). This positive earnings surprise likely contributed to past stock price appreciation. However, the trend is inconsistent, with one miss in the recent past.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $0.14B    | 61.47%        |
| 2024-12-31 | $0.12B    | 59.21%        |
| 2024-09-30 | $0.11B    | 55.94%        |
| 2024-06-30 | $0.11B    | 60.59%        |
| 2024-03-31 | $0.10B    | 61.91%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE   |
|------------|-----------|-------|
| 2025-03-31 | $0.27B    | 9.64% |
| 2024-12-31 | $0.23B    | 3.00% |
| 2024-09-30 | $0.21B    | 2.01% |
| 2024-06-30 | $0.19B    | 6.42% |
| 2024-03-31 | $0.16B    | 7.65% |

**Analysis:**

*   **Revenue:** Revenue has been steadily increasing over the past five quarters, indicating healthy growth.
*   **Profit Margin:** The profit margin remains consistently high, suggesting strong operational efficiency.
*   **Equity:** Equity has also shown consistent growth, reflecting increased shareholder value.
*   **ROE (Return on Equity):** ROE has fluctuated, with a significant increase in the most recent quarter. This indicates improved profitability relative to equity.

### 7. Overall Analysis

TMDX has demonstrated significant outperformance compared to the S&P 500, driven by strong revenue growth, high-profit margins, and positive earnings surprises. However, the stock exhibits high volatility, as reflected in its MDD. Recent price action suggests a short-term downward trend, corroborated by the RSI and PPO indicators. The Hybrid Signal advocates for a cautious stance. Recent news highlights potential risks and uncertainties.

**Investment Recommendation:**

Given the high expected return and strong financial performance, TMDX may be considered a suitable candidate for long-term investment. However, the recent downward trend and increased volatility warrant caution. Investors should closely monitor company news, analyst reports, and market conditions before making any investment decisions. Consider implementing a dollar-cost averaging strategy to mitigate the risk associated with the stock's volatility.
